Skip to content

A Pharmaceutical Analytical and Exploratory Study of Salsaradi Gana Processed with Shilajatu in the Treatment of Madhumeha

A Pharmaceutico-Analytical And Exploratory Study Of Salsaradi Gana Bhawit Shilajatu In The Management Of Madhumeha - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086942
Enrollment
30
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Post Graduate Institute of Ayurved Jodhpur Rajasthan
Lead Sponsor
Dr Mahaveer singh ashiya
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patient giving the clinical history of Madhumeha Presence of cardinal symptoms of diabetes mellitus eg 3P Polyuria Polydipsia Polyphagia Patient fasting blood sugar level is 126mg per dl to 200mg per dl and Post Prandial Blood Sugar PPBS level is 200mg per dl to 350mg per dl The fresh diagnosed case of type II DM will include

Exclusion criteria

Exclusion criteria: Patients below 30 year and above 65 years will be excluded Pregnant women or the women planning to be pregnant in next 6 month lactating mother CVS disorder CAD CNS disorder eg encephalopathy Patient of type II DM who are on insulin therapy Patient of type I DM

Design outcomes

Primary

MeasureTime frame
Change In Subjective And Objective ParameterTimepoint: 90 days

Secondary

MeasureTime frame
Improvement in Quality of life of PatientTimepoint: 90 days

Countries

India

Contacts

Public ContactMahaveer singh ashiya

PGIA Jodhpur

drcbsharma42@gmail.com9571779217

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026